En la esclerosis sistémica, el esófago se afecta en un 90%, seguido de los tramos anorrectal (%), gástrico ( 70%), colon (%) e intestino delgado. La esclerodermia es un relativamente infrecuente enfermedad reumática autoinmunitaria que afecta la piel y otros órganos del cuerpo. La esclerosis sistémica es una enfermedad autoinmune del tejido conectivo, que se caracteriza por un depósito excesivo de tejido colágeno y otros.
|Published (Last):||7 October 2014|
|PDF File Size:||5.30 Mb|
|ePub File Size:||16.19 Mb|
|Price:||Free* [*Free Regsitration Required]|
Treatment of systemic sclerosis is based upon 3 types of medications modifiers of disease: Drugs that prevent vascular damage such as: In contrast, the results of treatment of fibrosis are discouraging and the D-penicilamine continues being a matter of controversy. The immunosupressor therapy with cyclophosphamide and distemica transplant of hematopoietic cells, may be beneficial.
The knowledge of the pathogenesis of systemic sclerosis to molecular level will lead to new treatment strategies.
There was a problem providing the content you requested
Treatment of systemic sclerosis. Hospital de Especialidades Dr. The knowledge of the pathogenesis of systemic sclerosis to molecular level will lead to new treatment strategies. Treatment of systemic sclerosis by potentially disease-modifying drugs.
Arthritis Rheum, 44pp. Ann Rheum Dis, 44pp. Arthritis Rheum, 42pp. BMJ,pp. Clin Exp Rheumatol, 11pp. Circulation,pp. Severe refractory fingertip ulcerations in a sistrmica with scleroderma: J Rheumatol, 32pp. Ann Rheum Dis, 64pp. Curr Opin Rheumatol, 17pp. Rheumatology, 41pp. Cochrane Database Syst Rev. Endothelin and collagen vascular disease: Intern Med, 33pp.
Digital ulcers in systemic sclerosis. Prevention by treatment with bosentan, an oral endothelin receptor antagonist. Arthritis Rheum, 50pp.
Hemorragia por telangiectasias en paciente con esclerosis sistémica
Bosentan therapy for pulmonary arterial hypertension. N Engl J Med,sisemica. Am J Cardiovasc Drugs, 6pp. Ibanez de Kasep, J. Long-term evaluation of colchicine in the treatment of scleroderma.
J Rheumatol, 6pp. Rheum Dis Clin North Am, 16pp. D-Penillamine therapy in progressive systemic sclerosis scleroderma.
Ann Intern Med, 97pp. A year prospective study of treatment of rapidly progressive systemic sclerosis with D-penicillamine. J Rheumatol, 18pp. High-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis.
Effect of D-penicillamine on pulmonary fibrosis in patients with systemic sclerosis. Ann Rheum Dis, 62pp. High-dose versus low-dose D-penicillamine in early sistemicz systemic sclerosis trial: Semin Arthritis Rheum, 33pp. Recombinant human relaxin in the treatment of scleroderma. A randomized, double-blind, placebo-controlled trial. Ann Intern Med,pp.
Treatment of systemic sclerosis with recombinant interferon-gamma. Arthritis Rheum, 35pp. Alpha interferon-2a Roferon-A in the treatment of diffuse cutaneous systemic sclerosis: Br J Rheumatol, 31pp.
Interferongamma in the treatment of systemic sclerosis: Br J Dermatol,pp. Interferon-alpha does not improve outcome at one year in patients with diffuse cutaneous scleroderma: Long-term treatment of patients affected by systemic sclerosis with cyclosporin A. Ann Ital Med Int, 16pp. Cyclosporine in systemic sclerosis. Results of a forty-eightweek open safety study in ten patients. Arthritis Rheum, 36pp. Etanercept esclerosiss treatment for diffuse scleroderma: Arthritis Rheum, 43pp. Sistemicca fibrosis and normalization of skin structure in scleroderma patients treated with thalidomide.
A randomized, controlled trial of methotrexate versus placebo in early diffuse scleroderma. Placebo controlled trial of methotrexate in systemic sclerosis. Mymensingh Med J, 14pp. Hemopoietic stem cell transplantation in rheumatic diseases —an update. Autoimmun Rev, 4pp. A phase I-II trial of autologous peripheral esflerosis stem cell transplantation in the sisgemica of refractory autoimmune disease. Ann Rheum Dis, 65pp.
Adult stem cells in the treatment ssclerosis autoimmune diseases. Animal models of systemic sclerosis: Curr Opin Rheumatol, 16pp. B thromboglobulin and platelet factor 4 in bronchoalveolar lavage fluid of patients with systemic sclerosis. Lancet,pp. Clinical significance of fibromyalgia syndrome in different Si continua navegando, consideramos que acepta su uso. Sistrmica improve our services and products, we use “cookies” own or third parties authorized to show advertising related to client preferences through the analyses of navigation customer behavior.
Continuing navigation will be considered as acceptance of this use. You can change the settings or obtain more information by clicking here. Are you a health professional able to prescribe or dispense drugs?